Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed (2016 - 2025)

CorMedix has reported Return on Capital Employed over the past 13 years, most recently at 5.13% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 5.13% for Q4 2025, up 1143.0% from a year ago — trailing twelve months through Dec 2025 was 5.13% (up 1143.0% YoY), and the annual figure for FY2025 was 10.56%, up 1666.0%.
  • Return on Capital Employed reached 5.13% in Q4 2025 per CRMD's latest filing, down from 33.21% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 39.92% in Q2 2025 and bottomed at 112.32% in Q2 2024.
  • Median Return on Capital Employed over the past 5 years was 48.43% (2022), compared with a mean of 41.13%.
  • The largest annual shift saw Return on Capital Employed tumbled -4101bps in 2024 before it soared 15224bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 44.05% in 2021, then dropped by -25bps to 54.93% in 2022, then decreased by -18bps to 64.98% in 2023, then soared by 90bps to 6.3% in 2024, then soared by 181bps to 5.13% in 2025.
  • Business Quant data shows Return on Capital Employed for CRMD at 5.13% in Q4 2025, 33.21% in Q3 2025, and 39.92% in Q2 2025.